A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT04513925 · COMPLETED
Trial details
- NCT number
- NCT04513925
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2025-05-27
- Enrollment
- 829
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.